Sunmax Biotechnology (Taiwan) Performance
| 4728 Stock | TWD 278.00 2.00 0.72% |
The entity has a beta of 0.18, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sunmax Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sunmax Biotechnology is expected to be smaller as well. At this point, Sunmax Biotechnology has a negative expected return of -0.0679%. Please make sure to validate Sunmax Biotechnology's jensen alpha, treynor ratio, and the relationship between the information ratio and total risk alpha , to decide if Sunmax Biotechnology performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sunmax Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Sunmax Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 778.6 M | |
| Total Cashflows From Investing Activities | -285.2 M |
Sunmax |
Sunmax Biotechnology Relative Risk vs. Return Landscape
If you would invest 29,150 in Sunmax Biotechnology Co on August 24, 2024 and sell it today you would lose (1,350) from holding Sunmax Biotechnology Co or give up 4.63% of portfolio value over 90 days. Sunmax Biotechnology Co is generating negative expected returns and assumes 1.3167% volatility on return distribution over the 90 days horizon. Simply put, 11% of stocks are less volatile than Sunmax, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sunmax Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sunmax Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sunmax Biotechnology Co, and traders can use it to determine the average amount a Sunmax Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0516
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 4728 |
Estimated Market Risk
| 1.32 actual daily | 11 89% of assets are more volatile |
Expected Return
| -0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sunmax Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sunmax Biotechnology by adding Sunmax Biotechnology to a well-diversified portfolio.
Sunmax Biotechnology Fundamentals Growth
Sunmax Stock prices reflect investors' perceptions of the future prospects and financial health of Sunmax Biotechnology, and Sunmax Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sunmax Stock performance.
| Return On Equity | 0.48 | |||
| Return On Asset | 0.28 | |||
| Profit Margin | 0.39 % | |||
| Operating Margin | 0.56 % | |||
| Current Valuation | 8.1 B | |||
| Shares Outstanding | 54.46 M | |||
| Price To Book | 7.26 X | |||
| Price To Sales | 5.86 X | |||
| Revenue | 1.04 B | |||
| EBITDA | 416.06 M | |||
| Book Value Per Share | 22.04 X | |||
| Cash Flow From Operations | 243.28 M | |||
| Earnings Per Share | 9.24 X | |||
| Total Asset | 1.48 B | |||
About Sunmax Biotechnology Performance
Evaluating Sunmax Biotechnology's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Sunmax Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sunmax Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Sunmax Biotechnology performance evaluation
Checking the ongoing alerts about Sunmax Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sunmax Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sunmax Biotechnology generated a negative expected return over the last 90 days | |
| About 41.0% of the company shares are owned by insiders or employees |
- Analyzing Sunmax Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sunmax Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Sunmax Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sunmax Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sunmax Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sunmax Biotechnology's stock. These opinions can provide insight into Sunmax Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Sunmax Stock Analysis
When running Sunmax Biotechnology's price analysis, check to measure Sunmax Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunmax Biotechnology is operating at the current time. Most of Sunmax Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sunmax Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunmax Biotechnology's price. Additionally, you may evaluate how the addition of Sunmax Biotechnology to your portfolios can decrease your overall portfolio volatility.